United States Biotechnology & Medical Research

Grace Therapeutics, Inc (GRCE)

Track

Track

Grace Therapeutics witnessed eleven insider trading transactions over the past ninety days, all representing buys. Total net value reached 778,088 USD. These acquisitions occurred following a negative earnings report. Despite a 19.4% stock price decline, executives and entities like Opaleye Management increased their holdings, reflecting significant accumulation activity during this period.
Ticker: GRCE Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Grace Therapeutics, Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
457.38
Quantity 33,125 +5.1%
Value US$2,464,536
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
269.05
Quantity 25,024 +38.9%
Value US$2,410,357
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
395.32
Quantity 59,152 -3.9%
Value US$1,088,866
Kohli Prashant Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.14
Quantity 100,000 +468.2%
Value US$214,000
Kohli Prashant Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.14
Quantity 100,000 +468.2%
Value US$214,000
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
2.09
Quantity 5,836 +0.2%
Value US$12,197
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
2.09
Quantity 5,836 +0.2%
Value US$12,197
Kohli, Prashant Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
2.14
Quantity 100,000 +468.2%
Value US$214,000
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
2.10
Quantity 9,393 +0.3%
Value US$19,699
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
2.10
Quantity 9,393 +0.3%
Value US$19,699
3.4
Opaleye Management Inc. Large shareholder
Transaction date
Purchase
Price
2.09
Quantity 11,608 +0.4%
Value US$24,206
3.2
Kavuru, Vimal Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
1.85
Quantity 676,371 +132.2%
Value US$1,250,001
3.2
Kavuru Vimal Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.85
Quantity 676,371 +132.2%
Value US$1,249,934
3.8
Olds, Donald John Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
2.05
Quantity 381
Value US$781
3.0
Olds Donald Non-Executive Director
Transaction date
Purchase
Price
2.05
Quantity 381 +inf%
Value US$781
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-01 2026-09-29 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
33,125 +5.1%
457.38
US$2,464,536 		33,125 +5.1% 457.38 US$2,464,536
2026-09-23 2026-09-23 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
25,024 +38.9%
269.05
US$2,410,357 		25,024 +38.9% 269.05 US$2,410,357
2026-09-23 2026-09-21 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
59,152 -3.9%
395.32
US$1,088,866 		59,152 -3.9% 395.32 US$1,088,866
2026-09-10 2026-09-09 B Purchase
Kohli Prashant

Chief Executive Officer

Executive Director
100,000 +468.2%
2.14
US$214,000 		100,000 +468.2% 2.14 US$214,000
2026-09-10 2026-09-09 B Purchase
Kohli Prashant

Chief Executive Officer

Executive Director
100,000 +468.2%
2.14
US$214,000 		100,000 +468.2% 2.14 US$214,000
2026-09-10 2026-09-09 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
5,836 +0.2%
2.09
US$12,197 		5,836 +0.2% 2.09 US$12,197
2026-09-10 2026-09-09 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
5,836 +0.2%
2.09
US$12,197 		5,836 +0.2% 2.09 US$12,197
2026-09-10 2026-09-09 B Purchase
Kohli, Prashant

Director of Issuer, Senior Officer of Issuer

Executive Director
100,000 +468.2%
2.14
US$214,000 		100,000 +468.2% 2.14 US$214,000
2026-09-10 2026-09-08 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
9,393 +0.3%
2.10
US$19,699 		9,393 +0.3% 2.10 US$19,699
2026-09-10 2026-09-08 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
9,393 +0.3%
2.10
US$19,699 		9,393 +0.3% 2.10 US$19,699
2026-08-19 2026-08-14 B Purchase
3.4
Opaleye Management Inc.
Large shareholder
11,608 +0.4%
2.09
US$24,206 		11,608 +0.4% 2.09 US$24,206
2023-09-28 2023-09-25 B Purchase
3.2
Kavuru, Vimal

Director of Issuer

Non-Executive Director
676,371 +132.2%
1.85
US$1,250,001 		676,371 +132.2% 1.85 US$1,250,001
2023-09-27 2023-09-25 B Purchase
3.2
Kavuru Vimal
Non-Executive Director Large shareholder
676,371 +132.2%
1.85
US$1,249,934 		676,371 +132.2% 1.85 US$1,249,934
2023-09-05 2023-08-31 B Purchase
3.8
Olds, Donald John

Director of Issuer

Non-Executive Director
381
2.05
US$781 		381 2.05 US$781
2023-09-05 2023-08-31 B Purchase
3.0
Olds Donald
Non-Executive Director
381 +inf%
2.05
US$781 		381 +inf% 2.05 US$781
Explore more

More insider trading research around Grace Therapeutics, Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America